Company Filing History:
1 out of 870 
1 out of 1,744 
1 out of 5,089 
Years Active: 2017
Title: Teresa Freire: Innovator in Mucin Glycoconjugates
Introduction
Teresa Freire is a prominent inventor based in Montevideo, Uruguay. She has made significant contributions to the field of glycobiology, particularly in the synthesis of mucin glycoconjugates. Her work has important implications for biological, pharmaceutical, and medical applications.
Latest Patents
Teresa Freire holds a patent for the "Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof." This invention relates to mucin glycoconjugates and outlines a process for their production. Notably, her invention provides mucin glycoconjugates that do not require a protein carrier, such as KHL, to induce an immune response, specifically anti-Tn IgG.
Career Highlights
Throughout her career, Teresa has worked with esteemed institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of mucin glycoconjugates and their applications.
Collaborations
Teresa has collaborated with notable professionals in her field, including Sylvie Bay and Claude Leclerc. These collaborations have further enriched her research and contributed to her innovative work.
Conclusion
Teresa Freire's contributions to the field of glycobiology through her patent and collaborations highlight her role as a leading inventor. Her work continues to influence the development of immunogenic applications in medicine.